Introduction
The utilization of immunohistochemical techniques for the localization of a variety of different antigens has had a profound impact on the practice of surgical pathology over the past decade (8) . Conceptual and technical refinements have led to the development of increasingly more sensitive methods, which may be applied retrospectively to tissue that has been prepared both for light microscopic and ultrastructural analysis (36) . These techniques exploit the sensitivity and specificity of antibodies as diagnostic reagents and enable the pathologist to expand morphological observations to include a variety of functional and biochemical parameters. These developments have led to major conceptual advances in our understanding of many different disease processes and clearly point the way to a new era in diagnostic pathology.
Immunohistochemical techniques have played a key role in studies of the distribution, function, and interactions of the polypeptide hormone-producing neuroendocrine cells. Although morphologists had noted the presence of widely dispersed intraepithelial clear cells for many years, the functional significance of these cells was unknown. Feyrter, in a series of studies beginning in the 1930s, suggested that some of these cells constituted a peripheral endocrine or "parakrine" system (14). Much of the recent work on this system was stimulated by the observations of A.G.E. Pearse and his colleagues, who showed that many of these cells in the gastrointestinal tract and in other sites had the capacity for Amine Precursor Uptake and Decarboxylation (APUD) (31) . It was suggested that each of these cells synthesized a polypeptide hormone and/or amine and that these products were stored within membrane-bound secretory granules. These widely dispersed cells contain a set of common enzymes, including neuron-specific enolase (34) . It has also become apparent that many of the gut hormones are also present within the nervous system where they arè Presented as part of the program at the 1982 Joint Meeting of the American and Japanese Histochemical Societies, held in Vancouver, British Columbia, Canada, July [20] [21] [22] [23] [24] 1982 .
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synthesized and secreted by neurons and where they may act as neurotransmitter substances (35) . In addition to their neuroendocrine and neurotransmitter roles, certain members of the APUD system have also been shown to have a paracrine function whereby the local release of hormone may modulate the functions of adjacent cells (26) . Regardless of their embryologic origin or their locations, it is apparent that dispersed neuroendocrine cells and neurons tend to express much of the same genetic information and that they are "neuroendocrine programmed" (32, 33) .
Pathology of the Dispersed Neuroendocrine Cells
The development of the APUD concept has had a major impact on the understanding of clinical disorders of the endocrine system (10) . Hyperplasia or neoplasia of any of the component cells of the dispersed neuroendocrine system may be associated with the elaboration of regulatory peptides and/or amines characteristic of the cell of origin or a variety of "ectopic" hormones (20) . The major tumor types, currently believed to originate from these cells, are summarized in Figure 1 . Despite their origins in different organ systems, these neoplasms share a series of similar morphological, biochemical, and physiological characteristics. In hematoxylin and eosin-stained sections, for example, the tumors often show solid, trabecular, or microglandular patterns of growth that are reminiscent of gastrointestinal carcinoid tumors. The more malignant variants often are indistinguishable from the small cell carcinomas of bronchogenic origin. Ultrastructurally, the neoplasms often contain secretory granules that may or may not resemble the granules of the normal cells from which the tumors are derived. Biochemically, the neoplasms express the ability for amine precursor uptake and decarboxylation and also contain neuron-specific enolase (31, 37) . Functionally, dissociated tumor cells in culture are electrically excitable and exhibit short duration all-or-none action potentials (38 level, and in some cases it has been possible to define new clinico-pathological entites on the basis of these studies. Immunohistochemical analyses for a battery of hormones have also been instrumental in the development of new classification systems for a variety of the neoplasms illustrated in Figure  1 . In the pituitary, for example, the traditional classification of tumors of the pars distalis into acidophilic, basophilic. and chromophobic cell types has now been replaced by a functional classification based on specific staining patterns for various anterior pituitary hormones (24) . In addition to providing data on histogenesis and on hormonal profiles, immunohistochemical techniques for different hormones have also been of value in determining the sites of origin of metastatic neoplasms, and in some cases, predicting biological behavior.
Hyperplasia and Neoplasia of Dispersed Neuroendocrine Cell Systems

Thyroidal C-Cells
The calcitonin (CT)-containing C-cells may be identified in the thyroid glands in a number of different species using a variety of immunohistochemical procedures. In the adult human thyroid, C-cells have a relatively restricted distribution and are concentrated at the junctions of the upper and middle thirds of the lateral lobes (11) . Thyroid glands from neonates contain more CT than do adult glands and up to 10 times the number of C-cells, as determined by morphometry. Although light microscopic studies suggested that C-cells occupied a para-or interfollicular position, ultrastructural studies revealed that these cells occurred exclusively in intrafollicular sites.
Medullary (solid) thyroid carcinoma (MTC) with amyloid stroma was first established as a definite clinico-pathologic entity in 1959, and subsequent studies have shown that this neoplasm is derived from the C-cells (11) . Further studies established that MTC could occur either sporadically or as part of genetically determined disorders with autosomal dominant modes of inheritance [Types II and III multiple endocrine neoplasia (MEN) syndromes}. Patients with MTC have elevated concentrations of CT in the plasma; moreover, administration of CT secretagogues, such as pentagastrin and calcium, has been shown to stimulate secretion of the hormone and has served as the basis for the detection of occult neoplasms and their precursors, C-cell hyperplasia, in kindreds with Types II and III MEN (17) . With the peroxidase-antiperoxidase (PAP) technique for CT, the full spectrum of proliferative C-cell abnormalities may be visualized directly within tissue sections and may be correlated with circulating levels of the hormones (11) . Diffuse C-cell hyperplasia is characterized by increased size and number of C-cells as compared to age-and sex-matched controls. As in normal glands, the Ccells occupy an exclusively intrafollicular position. These relationships are maintained in areas of more severe hyperplasia where C-cells often encircle and centrally displace the follicular epithelium. Nodular hyperplasia of C-cells is characterized by complete obliteration of the follicular space by C-cells, while early invasive MTC is heralded by the extension of Ccells beyond the basal lamina of the follicle.
In the clinical assessment of patients with MTC, it is of great importance to determine the familial or sporadic nature of the tumors. Recent studies have indicated that all hereditary tumors are associated with C-cell hyperplasia in areas adjacent to tumor, while none of the sporadic cases had associated Ccell proliferative abnormalities (11) . The correct pathological identification of patients with the hereditary form of the disease on the basis of finding associated C-cell hyperplasia permits the selection of kindreds for regular screening studies of CT abnormalities.
Immunoperoxidase techniques are of great value for the specific identification of cases of MTC. These tumors may lack an amyloid stroma and may show considerable variation in their cytological features. Both follicular and papillary variants of these tumors have been described and occasional cases may show spindle or small cell undifferentiated patterns of growth. These variants may be impossible to differentiate histologically from tumors of follicular cell origin and immunohistochemical stains for CT and thyroglobulin (TGB) may be required for the correct diagnosis. Bocker et al. have reported that virtually all follicular carcinomas and more than 90% of papillary carcinomas contain immunoreactive TGB, while no cases of MTC stained for TGB (4) . We have observed occasional cases of MTC in which intercellular deposits of TGB are present, particularly at the junctions of the tumors with normal thyroid parenchyma. Some of this staining may represent entrapment of normal thyroid tissue within the tumor. Occasional tumor cells in these areas may also show faint TGB-like immunoreactivity, suggesting either diffusion or phagocytosis of TGB in these instances.
Recently, however, Kameda et al. have reported the presence of a C-cell-associated TGB both in normal and neoplastic C-cell populations (22) . The C-TGB is a 27S glycoprotein, while the major fraction of TGB has a molecular weight of 19S. Although the biochemical nature of the C-TGB is unknown, some studies have suggested that it may represent a CT precursor. Clearly, additional studies are required to determine the significance of TGB immunoreactants in MTC.
MTCs may contain a number of other regulatory peptides in addition to CT. These include somatostatin (SRIF), adrenocorticotropin (ACTH), vasoactive intestinal peptide (VIP), prolactin production stimulating activity, corticotropin releasing factor-like reactivity, and neurotensin (NT)-like immunoreactivity (10, 12) . In cases of human MTC, SRIF has been localized to subpopulations of tumor cells and has also been identified in foci of hyperplastic C-cells (10) . These studies indicate that MTC, similar to other tumors of the dispersed neuroendocrine system, are frequently multihormonal and may synthesize regulatory peptides that are normally present in Ccells as well as a variety of "ectopic" hormones.
Carcinoembryonic (CEA) antigen levels have been found to be elevated in patients with MTC, and in general, levels of this marker have paralleled the extent of the disease (11) . Immunohistochemical studies have revealed that this marker is present both within the cytoplasm and within plasma membranes of tumor cells. We have observed occasional cases of MTC that during the course of neoplastic progression, have lost the ability to synthesize CT. In these cases the CEA levels have continued to increase with increasing tumor burden while CT levels may be quite low. Recent studies have shown that the enzyme histaminase represents another useful marker for MTC. Mendelsohn and co-workers have found that while this enzyme is present in MTC cells, it is absent in foci of C-cell hyperplasia (29) . Additional studies will be required to confirm this interesting observation.
At the ultrastructural level, both normal and neoplastic Ccells have been shown to contain two major classes of secretory granules that differ both in size and density. Type I granules have an average diameter of 280 nm with moderately electrondense matrices and closely applied limiting membranes. Type II granules measure 130 nm in diameter and have an electrondense core that is separated from the limiting membrane by a narrow halo (11) . The two granule types have been shown to contain CT both with the PAP technique and with the protein-A colloidal gold method. These findings clearly indicate that the same hormonal product may be present in secretory granules of vastly different morphologies.
Pancreatic Endocrine Cells
The islets of Langerhans comprise approximately 1% of the pancreatic volume in humans. Traditionally, the islets have been considered to contain three cell types, namely, alpha, beta, and delta, that were thought to be responsible for the synthesis and secretion of glucagon, insulin, and gastrin, respectively. Recent studies, however, have indicated that there may be as many as nine different cell types within the islets which may contain a variety of regulatory peptides (13) . It has also been shown that the major secretory product of the delta or D-cells is SRIF rather than gastrin and that gastrin is not present in adult pancreatic tissue. Immunohistochemical studies indicate that a significant proportion of endocrine cells are present in extrainsular sites within the pancreatic parenchyma, particularly in association with pancreatic ducts.
Neoplasms of the pancreatic endocrine cells may give rise to a series of well-defined clinical syndromes that are related to the uncontrolled release of specific secretory products into the circulation (Figure 2 ). Although some investigators have suggested that it may be possible to predict the major hormonal products on the basis of histological characteristics, other workers have failed to confirm this observation. Histological stains often lack sufficient sensitivity and specificity to be of value for the analysis of pancreatic endocrine neoplasms. In addition, electron microscopy may not be of use in determining the specific type of hormone production, since poorly differentiated endocrine neoplasms and those tumors showing a high rate of protein turnover may contain relatively few secretory granules differing in their characteristics from their nonneoplastic counterparts. Immunohistochemistry remains the method of choice for the specific demonstration of the secretory products in these neoplasms. These techniques are of particular value in those pancreatic endocrine neoplasms that are not associated clinically with typical signs and symptoms of hormone overproduction.
In addition to providing data on hormonal profile, immunohistochemical techniques may also provide data on the biological behavior of these neoplasms with regard to their malignant potential. Recent studies, for example, have shown that the presence of the alpha chain of human chorionic gonadotropin (HCG) both in the plasma and in tissues is highly predictive of malignant behavior in these tumors (23) . Biological behavior may also be correlated with the major hormonal species secreted by the tumor (6). Thus, while 80 to 90% of insulinomas are benign, the vast majority of gastrin-and somatostatin-producing neoplasms are malignant. Approximately 75% of glucagonomas and 60% of vasoactive intestinal peptide producing pancreatic endocrine neoplasms are malignant. Detailed immunohistochemical studies of these neoplasms have shown that many are multihormonal (19) . A gastrinoma, for example, that shows gastrin immunoreactivity in most of the component cells may also contain immunoreactive insulin, glucagon, SRIF, or pancreatic polypeptide (PP). Whether the presence of multiple hormones in pancreatic endocrine neoplasms provides evidence of multiclonal origin, genetic derepression, or the development of tumor from an uncommitted stem cell has not, as yet, been resolved. It is apparent, however, that the demonstration of multiple hormones in these tumors may be of value in identifying those patients who may have mixed endocrine syndromes. The demonstration of these various peptides, particularly in small biopsy specimens of pancreatic neoplasms, will provide evidence of the endocrine nature of the tumor and also will provide the clinician with a series of markers that may be extremely useful in following the clinical course of the disease.
PP has been reported to occur in a relatively high proportion of multihormonal pancreatic endocrine neoplasms (19) . In this regard, Friesen et al. have studied plasma PP as a marker to detect pancreatic tumors in patients with Type I MEN (15) . Elevated basal and stimulated (after a test meal) levels of PP identified three patients with endocrine tumors of the pancreas. Normal basal but elevated stimulated levels in patients with Type I MEN were associated with various combinations of islet cell hyperplasia, antral G-cell hyperplasia, or parathyroid hyperplasia in these individuals.
Gastrointestinal Endocrine Cells
The gastrointestinal tract contains an extensive system of polypeptide hormone and amine-producing neuroendocrine cells (3). Knowledge of their distributional patterns has been made possible by development of both specific radioimmunoassays and immunohistochemical techniques. Some of these peptides, such as SRIF, are distributed throughout the gastrointestinal tract, while others have a more restricted distribution. Gastrin, for example, is present in highest concentrations in the gastric antrum, with progressively lower levels in the duodenum and proximal jejunum. NT and PP, on the other hand, are present in highest concentrations in the distal ileum and distal colon, respectively (3). The pathophysiology of the various gastrointestinal endocrine cells is just beginning to be explored. Pronounced degrees of G-cell hyperplasia, for example, have been described in association with atrophic gastritis, pernicious anemia, and retained excluded antrum (25) . In these cases, G-cell hyperplasia is thought to be secondary to a decrease or absence of hydrochloric acid. In some cases of Zollinger-Ellison syndrome, unassociated with tumors of the pancreas, stomach, or duodenum, an apparent primary hyperplasia of the G-cells has been described (25) . It is likely that similar alterations may occur in association with defined clinical syndromes in other portions of the gastrointestinal tract.
Carcinoid tumors classically have been thought to derive from the gastrointestinal argentaffin or argyrophil cells. These tumors have been divided into three major groups on the basis of their sites of origin within the gastrointestinal tract and on their reactivity with silver stains. Foregut carcinoids are typically argentaffin negative and argyrophil positive, while midgut carcinoids are both argentaffin and argyrophil positive. Hindgut carcinoids are rarely argentaffin positive, but may show argyrophilia in a small proportion of the cells. More recent studies indicate that carcinoid tumors may also be classified on the basis of their contents of specific polypeptide hormones. Foregut carcinoids may contain ACTH, glucagon, VIP, GIP, insulin, or PP, while substance P is found frequently in midgut carcinoids (1). Hindgut carcinoids have been reported to contain enteroglucagon, SRIF, PP, enkephalin, and /3-endorphin (30) . Similar to pancreatic endocrine neoplasms, intestinal carcinoids are frequently multihormonal. These findings indicate that carcinoid tumors represent a heterogeneous group of neoplasms with regard to their hormonal profiles. The finding of multiple hormone expression together with mucus-and lysozyme-containing Paneth granules in some cases suggests that these tumors may arise from crypt stem cells (21) . Tumors that contain only polypeptide hormones may arise from already committed endocrine-programmed cells, which may synthesize one or more polypeptide hormones.
Bronchopulmonary Endocrine Cells
Neuroendocrine cells similar to those in the gastrointestinal tract have also been found in the bronchial and bronchiolar epithelium, both in human fetuses and adults. Three types of neuroendocrine P-cells, which differ in granule size and density, have been identified in fetal lung (5) . The so-called Pacells are the characteristic endocrine cell of the adult lung and have secretory granules that measure 100-120 nm in diameter. Wharton et al. (40) first described the presence of the tetradecapeptide, bombesin, in fetal and neonatal lung in 1978, and CT-like immunoreactivity has also been described in the pulmonary endocrine cells in humans (2). There is now considerable morphological and physiological data to suggest that both carcinoid tumors and oat cell carcinomas are derived from the bronchopulmonary endocrine cells. These tumors contain cells that are electrically excitable, exhibit common cytochemical and ultrastructural features, and contain neuron-specific enolase. Similar regulatory peptides, including /3-endorphin, ACTH, CT, and bombesin, are also present in these neoplasms (10) .
Adrenal Medulla and Extra-Adrenal Paraganglia
Although the adrenal medulla and extra-adrenal paraganglia have been regarded primarily as sites of synthesis of catecholamines, recent studies have indicated that these tissues may also contain a variety of regulatory peptides, including CT, leu-and met-enkephalin (ENK), VIP, SRIF, and substance P (27, 41) . While some of these peptides have been localized within nerve fibers, others are present within adrenal medullary cells, paraganglionic chief cells, or neurons in normal and neoplastic states. In a recent study, leu-ENK immunoreactivity was found in small groups of cells in 4 out of 6 normal human adrenal medullas. In contrast, all cases of diffuse and nodular adrenal medullary hyperplasia contained leu-ENK immunoreactivity, which was more extensively distributed than in normal medullary tissue. Approximately 50% of pheochromocytomas and extra-adrenal paragangliomas, while no cases of neuroblastoma or ganglioneuroma, were positively stained (9) . VIP has been found in normal ganglion cells and in neoplastic ganglion cells in ganglioneuromas, ganglioneuroblastomas, and in pheochromocytomas with ganglionic differentiation (28) . The presence of VIP in these tumors has been correlated with the syndrome of watery diarrhea and hypokalemia (Verner-Morrison syndrome).
Other Neuroendocrine Cells
Intraepithelial clear cells similar to those found in the gastrointestinal tract have been found in a variety of different tissues and organs. In the breast and female genital tract, for example, argyrophilic cells have been identified and tumors in these sites, which may have the morphological features of carcinoids or small cell undifferentiated carcinomas, have been reported (7, 39) . The thymus also contains an extensive system of neuroendocrine type cells, particularly in avian species (18) . In humans, both carcinoid-type tumors and oat cell carcinomas may arise from the thymus and may be associated with the production of ACTH, SRIF, or CT (10, 20) . A similar set of regulatory peptides has been reported in some neuroendocrine carcinomas of the skin (Merkel cell tumors) (16) .
Conclusions
To date immunocytochemistry at the light microscopic and ultrastructural levels has contributed substantially not only to the identification of neuroendocrine programmed cell systems in humans, but also to the identification and classification of pathologic changes in these systems and to the correlation of pathologic features with clinical and functional parameters. In the future, these techniques will continue to be key probes for extending our current knowledge of these systems in health and disease, particularly in the study of endocrine and neuroendocrine mechanisms at the molecular level. 
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